CONGENITAL EYELID MALFORMATION

CONGENITAL EYELID MALFORMATION was reported 129 times

CONGENITAL EYELID MALFORMATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0002
1 Sulfone [EPC] 2 0.0002
2 Mood Stabilizer [EPC] 39 0.0002
3 Anti-epileptic Agent [EPC] 35 0.0002
4 Vitamin K [EPC] 1 0.0001
5 Nitrofuran Antibacterial [EPC] 2 0.0001
6 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
7 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
8 Typical Antipsychotic [EPC] 1 0.0000
9 Vitamin D [EPC] 9 0.0000
10 Vitamin B12 [EPC] 9 0.0000
11 Azole Antifungal [EPC] 4 0.0000
12 Protease Inhibitor [EPC] 1 0.0000
13 Vitamin C [EPC] 9 0.0000
14 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
15 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
16 Cardiac Glycoside [EPC] 1 0.0000
17 Retinoid [EPC] 3 0.0000
18 Nitrate Vasodilator [EPC] 1 0.0000
19 Atypical Antipsychotic [EPC] 5 0.0000
20 Aminosalicylate [EPC] 1 0.0000
21 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
22 Benzodiazepine [EPC] 6 0.0000
23 Alkylating Drug [EPC] 2 0.0000
24 Platinum-based Drug [EPC] 2 0.0000
25 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
26 Thiazide Diuretic [EPC] 1 0.0000
27 Corticosteroid [EPC] 6 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 2 0.0000